# Measurement of vanilloïd Compounds in Urin of Autistic vs Control Patients, as Potential Biomarkers

> **NCT04651972** · — · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 140 (estimated)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04651972
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-15
- **Primary completion:** 2022-07-30
- **Final completion:** 2022-07-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2020-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04651972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04651972, "Measurement of vanilloïd Compounds in Urin of Autistic vs Control Patients, as Potential Biomarkers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04651972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*